{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:27:23Z","timestamp":1792272443606,"version":"4.4.0"},"reference-count":76,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of cancer treatment with no effective preventative strategy or definitive treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To synthesize empiric literature from randomized controlled trials (RCTs) of pharmacological and nonpharmacological management of CIPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>Articles published between January 1, 2010, and February 28, 2021, were identified using keywords searching Medline, PubMed, CINAHL, Web of Science, Cochrane Library, and Embase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection:<\/jats:title>\n                    <jats:p>RCTs that recruited individuals who were post-chemotherapy and experienced persistent CIPN symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction and Synthesis:<\/jats:title>\n                    <jats:p>Three independent reviewers screened a total of 2023 abstracts. After screening, full-text review, and quality appraisal, 22 articles were included in this review. Data related to study design, participant characteristics, interventions, controls, outcome measures, and relevant findings were extracted from full texts. Descriptive quantitative summaries were calculated and narrative analysis was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 22 studies, 4 investigated pharmacologic treatments, 2 compared acupuncture to pharmacologic treatments, and 16 studies examined nonpharmacologic treatments. Pharmacologic studies reported mixed results with evidence of participant response varying by history of chemotherapeutic agent. Acupuncture, exercise\/physical therapy, and neurofeedback appear to be effective treatments for CIPN. Evidence regarding biophysical agents and cognitive-behavioral therapy is equivocal. Scrambler therapy is not supported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Studies included in this review share several limitations, including widely variable outcome measures, small and demographically homogenous samples, and nonstandardized treatment protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This scoping review summarized the current body of high-quality RCTs investigating treatment for CIPN. The majority of studies in this review reports benefits of pharmacologic and nonpharmacologic interventions, although management may require a multipronged approach and should be tailored to the individual. Clinical implications are proposed and suggestions made for future research include implementation of standardized intervention protocols, use of outcome measures representative of the spectrum of CIPN symptoms, and stratification by the chemotherapeutic agent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jpm.2021.0512","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T02:48:50Z","timestamp":1644202130000},"page":"964-995","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":34,"title":["Pharmacological and Nonpharmacological Management of Chemotherapy-Induced Peripheral Neuropathy: A Scoping Review of Randomized Controlled Trials"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-8394","authenticated-orcid":false,"given":"Katie Fitzgerald","family":"Jones","sequence":"first","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Wechsler","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Institute for Health Professionals, School of Rehabilitation Science, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zulewski","sequence":"additional","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Wood","sequence":"additional","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24951"},{"key":"e_1_3_4_4_2","first-page":"292","article-title":"Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors","volume":"51","author":"Eckhoff L","year":"2015","unstructured":"Eckhoff L, , Knoop A, , Jensen MB, , Ewertz M: Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer 1990, 2015; 51:292\u2013300.","journal-title":"Eur J Cancer 1990"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4230-8"},{"key":"e_1_3_4_6_2","first-page":"e13011","article-title":"Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer","volume":"28","author":"Tanay MA","year":"2019","unstructured":"Tanay MA, , Armes J: Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer. Eur J Cancer Care, 2019; 28:e13011.","journal-title":"Eur J Cancer Care"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3329-5"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3939-0"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-1766-y"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20090405"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0963"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-011-1127-7"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3552"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208573"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004272"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.09.006"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-4013-0"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399"},{"key":"e_1_3_4_19_2","first-page":"571","article-title":"Treatment of chemotherapy-induced peripheral neuropathy: Systematic review and recommendations","volume":"21","author":"Hou S","year":"2018","unstructured":"Hou S, , Huh B, , Kim HK, et al.: Treatment of chemotherapy-induced peripheral neuropathy: Systematic review and recommendations. Pain Physician, 2018; 21:571\u2013592.","journal-title":"Pain Physician"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_3_4_22_2","unstructured":"Cancer.Net. Cancer Survivorship Guide: https:\/\/www.cancer.net\/sites\/cancer.net\/files\/vignette\/Cancer_Survivorship.pdf 2011. (Last accessed September 20 2021)."},{"key":"e_1_3_4_23_2","unstructured":"Covidence. Covidence systemic review software. Melbourne: Veritas Health Innovation. https:\/\/www.covidence.org (Last accessed March 18 2020)."},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3201"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1188\/14.CJON.S3.68-79"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2014.0222"},{"key":"e_1_3_4_27_2","unstructured":"Brice R : CASP Checklists . CASP\u2014Critical Appraisal Skills Programme. https:\/\/casp-uk.net\/casp-tools-checklists (Last accessed September 23 2021)."},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534735420925519"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3871"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.11.013"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0681"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa048"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.11.025"},{"key":"e_1_3_4_34_2","author":"D'Alessandro EG","unstructured":"D'Alessandro EG, , Nebuloni Nagy DR, , de Brito CMM, et al.: Acupuncture for chemotherapy-induced peripheral neuropathy: A randomised controlled pilot study. BMJ Support Palliat Care 2019. DOI: 10.1136\/bmjspcare-2018-001542.","journal-title":"BMJ Support Palliat Care"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2158-7"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-3037-z"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001577"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2504674"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5522-7"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2017.11.009"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2813"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-3060-7"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04881-3"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0489"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.02.018"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30649"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2018.01.010"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/bem.22005"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/349653"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/0825859719827589"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4531-4"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0383"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.4103\/jrms.JRMS_1068_17"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419886662"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1089\/acu.2017.1242"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz087"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2019.08.005"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.REO.0000000000000238"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1159\/000442253"},{"key":"e_1_3_4_60_2","first-page":"479","article-title":"Rehabilitation of balance disturbances due to chemotherapy-induced peripheral neuropathy: A pilot study","volume":"52","author":"Cammisuli S","year":"2016","unstructured":"Cammisuli S, , Cavazzi E, , Baldissarro E, , Leandri M: Rehabilitation of balance disturbances due to chemotherapy-induced peripheral neuropathy: A pilot study. Eur J Phys Rehabil Med, 2016; 52:479\u2013488.","journal-title":"Eur J Phys Rehabil Med"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3875-5"},{"key":"e_1_3_4_62_2","first-page":"3849","article-title":"Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy","volume":"27","author":"McCrary JM","year":"2019","unstructured":"McCrary JM, , Goldstein D, , Sandler CX, et al.: Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. Support Care Cancer, 2019; 27:3849\u20133857.","journal-title":"Support Care Cancer"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.4081\/oncol.2015.263"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-017-0065-6"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2018.01039"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.17761\/2020-D-18-00030"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419850627"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2773-y"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1136\/acupmed-2016-011112"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-014-0411-1"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/bem.21897"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.01.020"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.5206"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.12.340"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kaaa101"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00086"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016358"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jpm.2021.0512","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2021.0512","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2021.0512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:13:50Z","timestamp":1777655630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jpm.2021.0512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1089\/jpm.2021.0512"],"URL":"https:\/\/doi.org\/10.1089\/jpm.2021.0512","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]}}}